TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An update from Proteomics International Laboratories Ltd. ( (AU:PIQ) ) is now available.
Proteomics International Laboratories Ltd announced that all resolutions at their Annual General Meeting were passed by poll. This outcome reflects strong shareholder support and may positively influence the company’s strategic initiatives and governance, potentially enhancing its position in the medical technology sector.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd, based in Perth, Western Australia, is a medical technology company specializing in precision diagnostics and bio-analytical services. The company focuses on proteomics, the large-scale study of proteins, aiming to enhance disease treatment through innovative diagnostic tools.
Average Trading Volume: 288,090
Technical Sentiment Signal: Sell
Current Market Cap: A$52.38M
For an in-depth examination of PIQ stock, go to TipRanks’ Overview page.